Asosiy kontentga oʻtish
Maqola

Characteristics of Glucocorticoid Resistance in Ankylosing Spondylitis

Vadim Vladimirovich KireevInstitute of Immunology and Human Genomics of the Academy of Sciences of the Republic Uzbekistan, Tashkent, UzbekistanAkram Amirculovich SuyarovInstitute of Immunology and Human Genomics of the Academy of Sciences of the Republic Uzbekistan, Tashkent, UzbekistanKhayrulla Musurmanovich KhatamovInstitute of Immunology and Human Genomics of the Academy of Sciences of the Republic Uzbekistan, Tashkent, Uzbekistan
2023en
ABI

Annotatsiya

Despite the fact that significant progress has been made in the treatment of ankylosing spondylitis, and basic drugs (methotrexate, sulfosalazine, etc.) are widely used, as well as various genetically engineered drugs that make it possible to achieve remission of the disease, glucocorticoid hormones continue to be one of the means of treating the disease, because they allow to achieve a sufficiently rapid decrease in the activity of the disease, as well as in the presence of systemic manifestations. Their use allows to reduce inflammatory activity, to stop the symptoms of inflammation and thereby to ease the condition of patients. The authors have established a different degree of sensitivity to various glucocorticoids, which must be taken into account during treatment.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar